Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia

Antonio Gidaro,Alessandro Palmerio Delitala,Alessandra Berzuini,Mark J. Soloski, Pietro Manca,Dante Castro,Emanuele Salvi,Roberto Manetti,Giorgio Lambertenghi Deliliers,Roberto Castelli

Journal of Clinical Medicine（2022）

引用 3|浏览10

暂无评分

关键词

low-risk myelodysplastic syndromes,refractory anemia,erythropoiesis-stimulating agent,erythropoietin,ferric carboxymaltose,ferric gluconate,iron supplementation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要